Literature DB >> 31978342

Establishing or Exaggerating Causality for the Gut Microbiome: Lessons from Human Microbiota-Associated Rodents.

Jens Walter1, Anissa M Armet2, B Brett Finlay3, Fergus Shanahan4.   

Abstract

Human diseases are increasingly linked with an altered or "dysbiotic" gut microbiota, but whether such changes are causal, consequential, or bystanders to disease is, for the most part, unresolved. Human microbiota-associated (HMA) rodents have become a cornerstone of microbiome science for addressing causal relationships between altered microbiomes and host pathology. In a systematic review, we found that 95% of published studies (36/38) on HMA rodents reported a transfer of pathological phenotypes to recipient animals, and many extrapolated the findings to make causal inferences to human diseases. We posit that this exceedingly high rate of inter-species transferable pathologies is implausible and overstates the role of the gut microbiome in human disease. We advocate for a more rigorous and critical approach for inferring causality to avoid false concepts and prevent unrealistic expectations that may undermine the credibility of microbiome science and delay its translation.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  causality; chronic disease; dysbiosis; fecal transplant; germ-free; gnotobiotic; human; humanized; microbiome; microbiota; murine models; rodents

Year:  2020        PMID: 31978342     DOI: 10.1016/j.cell.2019.12.025

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  107 in total

Review 1.  Challenges and emerging systems biology approaches to discover how the human gut microbiome impact host physiology.

Authors:  Gordon Qian; Joshua W K Ho
Journal:  Biophys Rev       Date:  2020-07-07

Review 2.  Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know?

Authors:  Lu Jiang; Bernd Schnabl
Journal:  Physiology (Bethesda)       Date:  2020-07-01

Review 3.  The gut microbiota-brain axis in behaviour and brain disorders.

Authors:  Livia H Morais; Henry L Schreiber; Sarkis K Mazmanian
Journal:  Nat Rev Microbiol       Date:  2020-10-22       Impact factor: 60.633

Review 4.  Uveitis and the gut microbiota.

Authors:  Shilpa Kodati; H Nida Sen
Journal:  Best Pract Res Clin Rheumatol       Date:  2020-04-09       Impact factor: 4.098

5.  Into the wild: microbiome transplant studies need broader ecological reality.

Authors:  Christopher J Greyson-Gaito; Timothy J Bartley; Karl Cottenie; Will M C Jarvis; Amy E M Newman; Mason R Stothart
Journal:  Proc Biol Sci       Date:  2020-02-26       Impact factor: 5.349

Review 6.  Microbiota on biotics: probiotics, prebiotics, and synbiotics to optimize growth and metabolism.

Authors:  Price T Edwards; Purna C Kashyap; Geoffrey A Preidis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-08-05       Impact factor: 4.052

Review 7.  Microbiota and Fatty Liver Disease-the Known, the Unknown, and the Future.

Authors:  Sonja Lang; Bernd Schnabl
Journal:  Cell Host Microbe       Date:  2020-08-12       Impact factor: 21.023

Review 8.  Deconstructing Mechanisms of Diet-Microbiome-Immune Interactions.

Authors:  Margaret Alexander; Peter J Turnbaugh
Journal:  Immunity       Date:  2020-08-18       Impact factor: 31.745

Review 9.  Microbial modulation of intestinal T helper cell responses and implications for disease and therapy.

Authors:  Markus B Geuking; Regula Burkhard
Journal:  Mucosal Immunol       Date:  2020-08-13       Impact factor: 7.313

Review 10.  Fueling Gut Microbes: A Review of the Interaction between Diet, Exercise, and the Gut Microbiota in Athletes.

Authors:  Riley L Hughes; Hannah D Holscher
Journal:  Adv Nutr       Date:  2021-12-01       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.